Melissa Kuenstler
Women's Health · Newton, ILNPI 1134469364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,556, more than ten times the $66 reported in 2021. Among women's health clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$519
- Novo Nordisk$435
- AstraZeneca$386
- Lilly USA, LLC$380
- AbbVie$308
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$261
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,627100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 26 | $519 |
| Novo Nordisk | 30 | $435 |
| AstraZeneca | 22 | $386 |
| Lilly USA, LLC | 21 | $380 |
| AbbVie | 23 | $308 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $261 |
| Novartis | 12 | $233 |
| Amgen | 12 | $204 |
| Boehringer Ingelheim | 6 | $136 |
| Axsome Therapeutics, Inc. | 7 | $123 |
| Mylan Specialty L.p. | 7 | $112 |
| GSK | 7 | $99 |
| Viatris Specialty LLC | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| Dexcom, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Abbott | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Exact Sciences | 2 | $29 |
| Pfizer | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| Grifols USA, LLC | 1 | $15 |
How this compares
$3,627 in reported general payments places this provider in the 95th percentile of 182 women's health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $32,264 |
| JardianceEmpagliflozin | 41 | $29,514 |
| RybelsusSemaglutide | 23 | $24,434 |
| EliquisApixaban | 29 | $17,773 |
| FarxigaDapagliflozin Propanediol | 15 | $12,495 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $8,110 |
| JanuviaSitagliptin Phosphate | 11 | $5,961 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,939 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 122 | $2,239 |
| Levothyroxine Sodium | 153 | $1,238 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,037 |
| Tramadol Hcl | 102 | $637 |
| Potassium Chloride | 45 | $633 |
| Gabapentin | 58 | $606 |
| Ventolin HfaAlbuterol Sulfate | 11 | $604 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $435 | $56,69858 claims |
| Boehringer IngelheimJardiance | $136 | $29,51441 claims |
| PfizerEliquis | $27 | $17,77329 claims |
| AstraZenecaFarxiga | $386 | $12,49515 claims |
| MerckJanuvia | $519 | $5,96111 claims |
| GSKBreo Ellipta | $99 | $5,93912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 182 women's health providers in Illinois.
Other women's health in Newton
- Debra GromleyDecatur$17K
- Carie EvansJerseyville$12K
- Miriam SciacchitanoChicago$10K
- Ashley WittlerShiloh$9K
- Nicole MiroballiHomewood$9K
- Patricia MurphyChicago$7K
- Summer HinthorneNormal$7K
- Jennifer NievesChicago$4K
- Sonia ReevesPekin$3K
- Lindsey FritzPeoria$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.